Novel Therapeutics: Response and Resistance of Ovarian Cancer

488

微信好友朋友圈 QQ好友复制链接

查看最新文献

发文信息

Novel Therapeutics: Response and Resistance of Ovarian Cancer - 最新文献

查看全部

Abstract NT-114: CATALYTIC SUBUNITS SWITCH DRIVES RESISTANCE TO EZH2 INHIBITORS IN ARID1A-MUTATED CELLS

Pub Date : 2019-11-15 DOI: 10.1158/1557-3265.ovcasymp18-nt-114 Shuai Wu, N. Fatkhutdinov, T. Fukumoto, Benjamin G. Bitler, P. Park, A. Kossenkov, M. Trizzino, Alessandro Gardini, D. Speicher, Rugang Zhang

Abstract NT-109: VAL-083 (DIANHYDROGALACTITOL) SYNERGIZES WITH PARP INHIBITORS IN BRCA-PROFICIENT AND BRCA-DEFICIENT OVARIAN CANCER MODELS

Pub Date : 2019-11-15 DOI: 10.1158/1557-3265.ovcasymp18-nt-109 A. Steinø, G. He, J. Bacha, Dennis Brown, Z. Siddik

Abstract NT-107: CHEMORESISTANT OVARIAN CANCER STEM CELLS REVEAL NOVEL THERAPEUTIC TARGETS

Pub Date : 2019-11-15 DOI: 10.1158/1557-3265.ovcasymp18-nt-107 Allison C Sharrow, Richard J. Jones, Lily Wu

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。

Book学术文献互助群
群号：481959085

文献互助智能选刊最新文献互助须知联系我们：info@booksci.cn